PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsHemorrhage
MeSH D006470 - hemorrhage
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010335:Pathologic processes
0 Companies
0 Drugs
Success rate
D006470: 
Hemorrhage
34 Companies
13 Drugs
$
Success rate
D004438:Ecchymosis
0 Companies
0 Drugs
Success rate
D004844:Epistaxis
0 Companies
0 Drugs
Success rate
D005130:Eye hemorrhage
0 Companies
0 Drugs
Success rate
D006395:Hemarthrosis
0 Companies
0 Drugs
Success rate
D006398:Hematocele
0 Companies
0 Drugs
Success rate
D006406:Hematoma
0 Companies
0 Drugs
Success rate
D006417:Hematuria
0 Companies
0 Drugs
Success rate
D006431:Hemobilia
0 Companies
0 Drugs
Success rate
D006465:Hemoperitoneum
0 Companies
0 Drugs
Success rate
D006469:Hemoptysis
0 Companies
0 Drugs
Success rate
D006471:Gastrointestinal hemorrhage
3 Companies
1 Drug
$
Success rate
D006472:Oral hemorrhage
0 Companies
0 Drugs
Success rate
D006491:Hemothorax
0 Companies
0 Drugs
Success rate
D011693:Purpura
5 Companies
1 Drug
$
Success rate
D012771:Hemorrhagic shock
30 Companies
3 Drugs
$
Success rate
D014592:Uterine hemorrhage
40 Companies
9 Drugs
$
Success rate
D016063:Surgical blood loss
0 Companies
0 Drugs
Success rate
D019106:Postoperative hemorrhage
0 Companies
0 Drugs
Success rate
D019315:Retrobulbar hemorrhage
0 Companies
0 Drugs
Success rate
D020300:Intracranial hemorrhages
0 Companies
0 Drugs
Success rate
D058734:Exsanguination
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Novast LaboratoriesDesmopressin Desmopressin  2019-06-06   
Glenmark PharmaceuticalsDesmopressin Desmopressin  2015-05-28   
NATCO PharmaDesmopressin Desmopressin  2014-06-27   
Boehringer IngelheimIdarucizumab Praxbind  2015-11-20   
AstraZenecaAndexanet alfa Ondexxya  2019-04-26   
Bausch Health CompaniesDesmopressin Desmopressin  1999-01-25   
BayerAprotinin Trasylol  1993-12-29   
Dr Reddys LaboratoriesDesmopressin Desmopressin  2022-08-19   
Zydus TherapeuticsDesmopressin Desmopressin  2017-10-03   
Sun Pharmaceutical IndustriesDesmopressin Desmopressin  2012-04-12   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
94%
15/16
Phase 2
73%
16/22
Phase 3
62%
33/53
Approved: 10Overall Success rate: 42%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Boehringer Ingelheim
Idarucizumab,
Dabigatran,
Vitamin k,
Serine
AstraZeneca
Andexanet alfa,
Disufenton sodium,
Terfenadine,
AZD6482,
Antacid,
Evidence
Bausch Health Companies
Terfenadine,
Sodium chloride,
Nahco3,
Antacid
Bayer
Aprotinin,
Chlormadinone acetate,
Ziv-aflibercept,
Serine,
Sodium chloride,
Sodium lactate,
Bevifimod,
Telbermin,
Vilaprisan,
Microcrystalline cellulose,
Valette,
Kcentra,
Amchafibrin,
Gestapuran,
Articular,
Arm1,
Arm2,
Depoprovera
Novo Nordisk
Turoctocog alfa,
Coagulation factor viia recombinant human,
Rfviia,
Demand
Ferring Pharmaceuticals
Desmopressin,
Ergometrine,
Carbetocin,
Ergonovine,
Amchafibrin,
Trinessa
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use